Frankfurt
09.10.26 | 08:03
0,044 Euro
-7,45 % -0,004
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,044 | 0,063 | 12:15 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| Mi | Ventripoint Diagnostics Ltd (2): Ventripoint to host video conference call Oct. 9 | 3 | Stockwatch | ||
| Di | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call | 3 | TheNewswire | ||
| 24.09. | Ventripoint Diagnostics Ltd (2): Ventripoint completes annual quality, regulatory audits | 3 | Stockwatch | ||
| 24.09. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 24.09. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits | 2 | TheNewswire | ||
| 14.09. | Ventripoint Diagnostics Ltd (2): Ventripoint issues 601,115 shares for interest owed | 3 | Stockwatch | ||
| 14.09. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Shares for Payment of Debenture Interest | 2 | TheNewswire | ||
| 12.09. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 601,115 shares for debt | 2 | Stockwatch | ||
| 09.09. | Ventripoint Diagnostics Ltd (2): Ventripoint closes financing tranche, hires advisers | 1 | Stockwatch | ||
| 08.09. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 08.09. | Ventripoint Diagnostics Ltd.: Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+ Technology | 1 | TheNewswire | ||
| 20.08. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 20.08. | UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform | 670 | ACCESS Newswire | Proposed collaboration would combine UniDoc's connected-care infrastructure with Ventripoint's AI-enabled cardiac imaging platform VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| 13.08. | Ventripoint broadens access to AI cardiac imaging | 3 | The Market Online Canada | ||
| 13.08. | Ventripoint Diagnostics Ltd (2): Ventripoint talks up VMS+ 4.0 access by subscription | 1 | Stockwatch | ||
| 12.08. | Ventripoint Diagnostics Ltd: Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging | 1 | GlobeNewswire (USA) | ||
| 07.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement | 1 | TheNewswire | ||
| 06.08. | Ventripoint Diagnostics Ltd (2): Ventripoint, UniDoc assess remote cardiac platform | 26 | Stockwatch | ||
| 05.08. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,180 | +0,93 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| TANDEM DIABETES | 13,500 | -3,57 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| MOLINA HEALTHCARE | 173,20 | -0,80 % | $1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today | ||
| VERU | 2,405 | -0,62 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,470 | +9,29 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SOMNIGROUP INTERNATIONAL | 55,22 | -0,72 % | Somnigroup International Q2 2026 Earnings Call: Complete Transcript | ||
| SINTX TECHNOLOGIES | 2,090 | 0,00 % | SINTX reports preliminary $2.2M Q3 revenue, exceeds guidance and triggers call right on Class B warrants | ||
| NEURONETICS | 1,960 | +2,35 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| FRESENIUS | 42,505 | +2,20 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,630 | +2,48 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,004 (-7,45 %) liegt der Kurs bei 0,044 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.